Physicians are employing ECMO technology to treat severe cases of the flu when conventional therapy fails.
Grant will allow researchers to study novel therapies for pulmonary fibrosis, a deadly lung disease with no approved treatments.
The therapy, approved for use in parts of Europe and Israel, is undergoing investigation in the United States as a potential method of reducing lung volume in patients with severe emphysema.
The new method is an improved form of optical coherence tomography, termed micro-OCT, which has been shown to provide valuable images of four different, difficult-to-measure parameters of airway health.